Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Invasive Group B Streptococcus (GBS) Disease”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Not applicableStudy completedNCT01888471
What this trial is testing

Feasibility Study for Identifying Anti Capsular Antibody Protection Against Invasive Group B Streptococcus (GBS) Disease in Newborns of 0-6 Days Age (Early Onset Disease [EOD]) as Well as Among Infants of 7-90 Days Age (Late Onset Disease [LOD])

Who this might be right for
Streptococcus Agalactiae
GlaxoSmithKline 3,033
Not applicableStudy completedNCT02215226
What this trial is testing

GBS Sero-correlate of Protection

Who this might be right for
Invasive Group B Streptococcus Disease
University of Witwatersrand, South Africa 35,274
Not applicableStudy completedNCT01933646
What this trial is testing

Burden of Invasive Group B Streptococcal (GBS) Disease in Young Infants in China

Who this might be right for
Invasive Group B Streptococcal Disease
Novartis Vaccines 10
Not applicableNot Yet RecruitingNCT06896526
What this trial is testing

Comprehensive Outcomes Monitoring for Peri- and Postnatal Invasive Group B Strep Sequelae (COMPPASS) Registry

Who this might be right for
Invasive Group B Streptococcus DiseaseGroup B StreptococcusGroup B Streptococcal Infection+3 more
Precia Group 10,000
Not applicableLooking for participantsNCT06833957
What this trial is testing

Preparing for Maternal GBS Vaccine Trials in Africa

Who this might be right for
Group B StreptococcusInvasive Bacterial Diseases (IBD)Maternal Immunization
Barcelona Institute for Global Health 18,100
Early research (Phase 1)Study completedNCT00657683
What this trial is testing

A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose Range of a Monovalent Glycoconjugate Antigen Vaccine of Group B Streptococcus in Healthy Women 18-40 Years of Age

Who this might be right for
Invasive Group B Streptococcus (GBS) Disease
Novartis Vaccines 65
Early research (Phase 1)Study completedNCT00645346
What this trial is testing

A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose Range of Glycoconjugate Antigen Vaccine of Group B Streptococcus in Healthy Women 18- 40 Years of Age

Who this might be right for
Invasive Group B Streptococcus (GBS) Disease
Novartis Vaccines 130
Not applicableUnknownNCT04653948
What this trial is testing

Maternal, Neonatal and Infant Outcomes at Kawempe National Referral Hospital

Who this might be right for
Group B Streptococcus Carrier in ChildbirthGroup B Streptococcal Infection, Late-OnsetGroup B Streptococcal Infection, Early-Onset+2 more
St George's, University of London 3,423